Formulary Chapter 1: Gastro-intestinal system - Full Chapter
Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand.
For oral mucositis and oesophageal lesions following chemotherapy/radiotherapy
Gaviscon Advance Liquid
Patients who require reduced salt intake
Use in A&E as pre-packs only (within ANHSFT)
Gaviscon Infant Dual Sachets
For paediatric use only
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Green - Drugs suitable for generalised use in accordance with position summary.
Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.
Amber - these drugs require specialist initiation or recommendation
Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
Red - Drugs for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.
Black - Drugs not routinely commissioned so should not usually be prescribed